R. Hecht

Full Issue: Volume 2, Number 1 Spring 2009

Rivka H. Borger, Michelle V Gordon, A. Degani, 2021 .

Anti-VEGF antibody bevacizumab (Avastin) with 5FU/LV as third line treatment for colorectal cancer

F. Kabbinavar, M. Pegram, C. Emmanouilides, 2004, Techniques in Coloproctology.

A Multi-Disciplinary Cancer Program Enhances Hereditary Colorectal Cancer Detection

Z. Wainberg, Percy Lee, S. Hart, 2014 .

3:36 PM Abstract No. 375 Early safety from a phase 1, multicenter, open-label clinical trial of talimogene laherparepvec (T-VEC) injected into liver tumors

S. Raman, E. Chan, A. Prat, 2018 .

Multi-center phase II/III randomized controlled clinical trial using TNFerade combined with chemoradiation in patients with locally advanced pancreatic cancer (LAPC)

Kenneth J. Chang, W. Fisher, M. Posner, 2007 .